 - DNMT and CTA expression levels in PBMC and tumor tissues will be evaluated before and after treatment to ascertain if DAC-THU depletes systemic DNMT levels, and to determine if alterations in DNMTCTA expression in PBMC can serve as surrogates of respective drug induced changes in tumor tissues. 